FdaApplication
ANDA 209446
Identifiers
- fda_app_no: ANDA209446
Properties
| Property | Value |
|---|---|
| applicant_name | SAWAI USA INC |
| application_type | ANDA |
| approval_date | 2019-12-27 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MIRABEGRON | MIRABEGRON | 25MG | TABLET, EXTENDED RELEASE;ORAL |
1 product